MetaCap

Addus HomeCare Corporation (ADUS)

NASDAQ: ADUSHealth CareMedical/Nursing ServicesUSD

122.50+1.43 (+1.18%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADUS stock chart

Technical analysis

Key statistics

All statistics
52-week range
87.95 – 131.59
Day range
119.26 – 123.29
Volume / Avg
254.34K / 220.25K
Beta
—

52-week range

$87.95$131.59

ADUS stock today

Shares of Addus HomeCare (ADUS) finished higher on Nov 20 at $122.50, a gain of 1.18% or $1.43 per share, versus the S&P 500's 3.70% decline. Shares are 6.9% below their 52-week high of $131.59, set on Nov 5, 2026 and 39.3% above the 52-week low of $87.95, in the middle of the past year's range. ADUS is up 14.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 8.7%.

At 20.4x trailing earnings, Addus HomeCare trades below the peer-group median of 65.3x. Its forward P/E of 16.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Addus HomeCare

Company profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living.

Industry
Medical/Nursing Services
CEO
Mr. R. Dirk Allison CPA
Headquarters
Frisco, TX
Employees
5,982
IPO year
2009
Website
addus.com

Financial highlights

Full financials

In fiscal 2025, Addus HomeCare generated $1.42 billion in revenue, up 23.2% from fiscal 2024, its 15th consecutive year of revenue growth. Net income was $95.9 million (+30.3% year over year), for a net margin of 6.7% versus a median of 5.2% in the prior 5 years. Gross margin was 32.5% (flat year over year) and operating margin 9.7%.

Addus HomeCare annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.42B$1.15B$1.06B$951.12M$864.50M
Growth+23.21%+9.06%+11.31%+10.02%+13.04%
Net income$95.91M$73.60M$62.52M$46.02M$45.13M
EPS (diluted)$5.22$4.23$3.83$2.84$2.81

Analyst forecast

Forecast

Consensus (14 analysts)

buy

Avg. price target

$141.46+15.48%

  • Strong buy 3
  • Buy 8
  • Hold 2
  • Sell 0
  • Strong sell 1

Target range

Low $101.00High $160.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$1.38 vs $1.61
Surprise
-14.29%

ADUS news

All ADUS news

Addus HomeCare peers

Health Care sector
ADUS peer companies
CompanyPrice% ChgMarket capCompare
AVAHAveanna Healthcare Holdings Inc.11.01+2.90%$2.40Bvs ADUS
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs ADUS
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs ADUS
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs ADUS
PRVAPrivia Health Group Inc.25.05+1.46%$3.20Bvs ADUS
INNVInnovAge Holding Corp.9.16+2.81%$1.25Bvs ADUS
PNTGThe Pennant Group Inc.34.64+1.61%$1.22Bvs ADUS
HIMSHims & Hers Health Inc. Class A14.60-8.86%$3.42Bvs ADUS

Indexes, lists and sector

Addus HomeCare stock FAQ

What is Addus HomeCare's stock price today?

ADUS last traded at $122.50 as of Nov 20, 4:00 PM EST, up 1.18% on the day. Prices are delayed at least 15 minutes.

What is ADUS's P/E ratio?

ADUS trades at a trailing P/E ratio of 20.38 and a forward P/E of 16.12, compared with a median of 65.3 for its closest peers.

Who is Addus HomeCare's CEO?

Mr. R. Dirk Allison CPA is the chief executive officer of Addus HomeCare Corporation, which has about 5,982 employees.

What is the ADUS 52-week high?

The 52-week high for ADUS is $131.59 and the 52-week low is $87.95. The stock is currently 6.9% below its high.

Compare ADUS